The latest thought leadership from our expert teams

Active filters (1)
Targeted therapies and drug delivery
Opinion

With technology innovation, pharma can drive targeted delivery and seize market opportunity

Nov 1, 2023

Technology innovations are now able to start realising health concepts that have been talked about for years. As Stephanie Mou explains, insurmountable market advantage awaits the organisation that can establish a compelling delivery platform over the next five years… 

  • AI & Analytics
  • Human factors
miniature implantable medical devices for drug delivery
Opinion

Drug delivery implant miniaturisation opens doors for disruptive innovation

Jul 28, 2023

What does the future of next generation implantable drug delivery devices look like? Harry Moorman believes a CC concept breakthrough in smart, miniaturised implant innovation offers significant opportunity for a market that is ripe for development and commercial growth…

  • Digital health
  • Human factors
  • Industrial design
  • User Experience (UX)
Powering the future of implantable medical devices
Opinion

Powering the future of implantable medical devices

Jul 20, 2023

One of the major questions to address when designing a new implantable medical device is how best to power it. Drawing on his extensive knowledge of the field, medical device development expert Neil Rosewell has identified the top six issues around smart implant power that developers need to bear in mind right now… 

  • Digital health
  • Electronics & ASICs
  • Sensing
  • User Experience (UX)
Quantum for pharma
Opinion

Quantum computing for pharma and life sciences – opportunities are on the horizon

Feb 21, 2023

What can quantum computing and quantum technology do for the pharma and life sciences industry? After reviewing the latest signs of quantum innovation in practice across Europe, Elizabeth Thomas has conferred with Cambridge Consultants’ quantum experts and now shares her insights into how organisations can start implementing an action plan… 

  • AI & Analytics
  • Physical sciences
  • Strategic advice
  • Synthetic biology
What does the future hold for precision medicine?
Opinion

What next for precision medicine?

Nov 22, 2022

The world of DNA testing is changing fast and the race is on to provide cheap, quick genetic diagnoses for patients. So what are the opportunities for companies working in this dynamic field?

  • AI & Analytics
  • Cell and gene therapy
Medtech Innovator Asia Pacific 2022 finalists
Opinion

Six innovative Asia medtech start-ups to watch

Oct 20, 2022

Asia’s medical technology market is predicted to account for a third of global medical technology sales by 2025. As such, it's a hotbed for start-ups, so here are our six innovative start-ups to watch that are part of this year’s MedTech Innovator cohort. 

  • Bioinnovation
  • Cell and gene therapy
  • Digital health
  • Innovation management
  • User Experience (UX)
2022 Cambridge Consultants Associate Prize for Breakthrough Design
Opinion

Celebrating award-winning design innovation in an underserved area of women’s health

Sep 23, 2022

The design and technology teams working in medical technology innovation at Cambridge Consultants are passionate about improving women’s healthcare. We were delighted to welcome to CC Aashi Srivastava, the winner of Cambridge Consultants ‘Excellence in Breakthrough Design’ at the New Designers award ceremony to hear more about her perineal tear recovery kit to aid new Mums. 

  • Digital health
  • Human factors
  • Industrial design
  • User Experience (UX)
The future of drug delivery lies in collaboration
Opinion

Collaboration is the key to unlocking a successful connected future for global pharma

Sep 5, 2022

Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering.

  • Bioinnovation
  • Digital health
  • Human factors
  • User Experience (UX)
start-up risk assessment
Opinion

Start-up technology can be risky business if threats aren’t tackled hard and early

Aug 19, 2022

Founders of early-stage start-ups are characteristically passionate, driven and optimistic. Understandably so. Very often they are nurturing a breakthrough idea with the capacity to disrupt business and change the world for the better. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong. 

  • AI & Analytics
  • Bioinnovation
  • Cell and gene therapy
  • Connectivity & IoT
  • Innovation management
  • Project management
  • Robotics
  • Strategic advice
  • Synthetic biology
Medtech Innovator APAC 2022
Opinion

MedTech Innovator is not a one-off, start-up nurturing is in our DNA

Aug 16, 2022

Yan Lin Lye and a team from CC are embarking on a sequence of mentoring sessions as part of our commitment to MedTech Innovator Asia Pacific. For the second consecutive year, we're collaborating with the organisation to provide hands-on professional support to selected start-up participants.

  • Bioinnovation
  • Cell and gene therapy
  • Strategic advice
  • Synthetic biology
cell therapy
Opinion

Our synthetic vision of affordable and accessible cell therapy for all

Jul 18, 2022

The emergence of cell-based therapy's is one of the most important human stories of our time. Read our synthetic vision of affordable and accessible cell therapy for all...

  • Bioinnovation
digital biomarkers
Opinion

Why digital biomarkers are vital for a patient-empowering connected health future

May 17, 2022

The pandemic has accelerated our path towards an inevitable conclusion – a digitally connected healthcare future that empowers both patients and carers alike. The opportunities are out there, so what’s the next step for pharma companies and device developers with ambitions in the space? 

  • Digital health